Kreatech Biotechnology, Corus Pharma, Sopherion Therapeutics, Zyomyx, Whitehead, MIT, Center for Integrated Electronics | GenomeWeb

Kreatech Takes In $6.6M Funding

Kreatech Biotechnology of Amsterdam recently received a third round of private equity financing of €6 million ($6.6 million) led by 3i Group, a London-based firm, joined by Life Sciences Partners of Amsterdam and Munich, and Alafi Capital of Berkeley, Calif. Kreatech engages in commercializing labeling and detection technology for protein and nucleic acid labeling applications.

 

Corus Inks $40M Series B

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PNAS this week: variation patterns in wheat lines, regulatory variation in Capsella grandiflora, and more.

A Rockefeller University researcher is using edited ants to explore complex biological systems, the New York Times writes.

There's a heritable aspect to how much time people spend online, the Los Angeles Times reports.

Stat News reports that Joseph Gulfo is another contender for FDA commissioner.